●  CARMAX INC · FY 2024 

Market Risk

Despite active efforts to hedge variable-rate debt, CARMAX maintains a material sensitivity to interest rate fluctuations stemming from its funding structures and pension obligations. Stress testing reveals that a 100-basis point increase in market rates related to non-recourse funding vehicles could decrease fiscal year net earnings per share by approximately $0.19. Furthermore, the company's cash-settled restricted stock units expose it entirely to equity price volatility without disclosed mitigation strategies.

KMX L1 Synthesis
●  SYMBOLOGY.ONLINE l1 SYNTHESIS 

Carmax Inc Market Risk Synthesis

Quantitative Market Risk Exposure Assessment

This assessment analyzes CARMAX INC's market risk disclosures from the 10-K filing dated February 29, 2024. The analysis focuses on identifying exposure magnitude, changes over prior periods, and mitigation strategies across key financial risks.

Interest Rate Sensitivity

CARMAX exhibits significant interest rate sensitivity stemming from its funding structures and pension obligations.

Exposure Magnitude and Changes

  • Non-Recourse Notes Payable: Total non-recourse notes payable increased from $16,360.1 million in 2023 to $16,867.0 million in 2024. The variable-rate portion of this debt saw a notable increase, rising from $5,943.7 million (2023) to $6,429.9 million (2024).
  • Other Debt: Borrowings under the revolving credit facility and term loans are substantially variable-rate based on SOFR.
  • Pension Obligation: The projected benefit obligation (PBO) of the pension plan is sensitive to interest rate changes, with a 100-basis point change in the discount rate having an approximate 15% effect on the PBO balance.

Mitigation Strategies and Quantitative Impact

  • Mitigation: Interest rate risk related to variable-rate debt (both non-recourse funding vehicles and other debt) is primarily mitigated through derivative instruments, which are used to manage differences between known/expected cash receipts and payments. A portion of the variable-rate risk in Other Debt is also managed by derivatives.
  • Quantitative Impact: The company provides specific stress test results:
    • A 100-basis point increase in market interest rates associated with non-recourse funding vehicles would decrease fiscal 2024 net earnings per share (EPS) by approximately $0.19.
    • A 100-basis point increase in market interest rates related to Other Debt would decrease fiscal 2024 EPS by approximately $0.02.

Assessment: Strengths and Weaknesses

  • Strength: The company actively uses derivative instruments to hedge variable-rate debt, demonstrating a proactive approach to managing funding risk.
  • Weakness: Despite hedging efforts, the exposure remains material, as evidenced by the significant potential EPS impact ($0.19) from a moderate interest rate increase in non-recourse funding vehicles. Furthermore, the effectiveness of these strategies could be disrupted by "Disruptions in the credit markets or unexpected changes in prepayment activity."

Equity Price Risk

Exposure to equity price risk is tied specifically to employee compensation liabilities.

Exposure Magnitude and Changes

  • Source: The company's cash-settled restricted stock units are liability awards, making the related compensation expense sensitive to fluctuations in the company’s stock price.
  • Magnitude: No prior period comparison for this specific exposure was provided.

Mitigation Strategies and Quantitative Impact

  • Mitigation: No explicit hedging strategies were disclosed for this risk.
  • Quantitative Impact: The filing quantifies the sensitivity: a 10% increase in the company's stock price would have affected fiscal 2024 net earnings per share by approximately $0.02.

Assessment: Strengths and Weaknesses

  • Strength: The risk is clearly identified and quantified, providing stakeholders with visibility into its potential impact on EPS.
  • Weakness: The reliance on liability awards means the company bears the full mark-to-market volatility of its stock price, and no mitigation strategies are disclosed to offset this exposure.

Foreign Currency Exposure

The provided market risk disclosures do not contain any information regarding foreign currency exposures (e.g., transactions or translation risks) involving specific currencies or related hedging activities.

Commodity Price Risk

The provided market risk disclosures do not contain any information regarding commodity price risks, key commodities involved, contract structures, or their impact on margins.

Quantitative Measures and Reporting

CARMAX utilizes quantitative measures to assess and report its financial vulnerabilities, primarily through sensitivity analysis (stress testing).

Disclosure Details

  • Measures Employed: The company provides specific EPS impacts based on defined changes in market variables (e.g., 100-basis point interest rate shifts, 10% stock price increases).
  • Reporting Strength: The disclosure is highly quantitative, moving beyond qualitative statements to provide concrete financial estimates of potential losses under stress scenarios.

Assessment: Strengths and Weaknesses

  • Strength: The use of specific EPS impact figures (e.g., $0.19 for a 100 bps rate hike) allows investors to directly model the financial consequences of market movements, enhancing transparency.
  • Weakness: While sensitivity tables are provided, there is no disclosure regarding comprehensive Value-at-Risk (VaR) metrics or detailed stress test results beyond the specific interest rate and equity scenarios presented.